SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1319<<One other thing is that it isn't very motivating to see Levin steppiMiljenko Zuanic-1/6/2003
1318<i>Millennium CEO Mark Levin said the company's goal is to restructureLondo-1/6/2003
1317Millennium's cash mountain. I got almost a scare when I read Feuerstein'Icebrg-1/6/2003
1316Millennium Warns of Widening Loss By Adam Feuerstein Senior Writer 01/06/2003 0Icebrg-1/6/2003
1315Millennium Sees 2003 Rev $450M-$475M DOW JONES NEWSWIRES SAN FRANCISCO -- Millbob zagorin-1/6/2003
1314Millennium Highlights 2003 Financial Outlook and Goals at JP Morgan H&Q Healbob zagorin-1/6/2003
1313MLNM moves break-even further out. Last year they said. >>"The year Icebrg-1/6/2003
1312Tuck--Yeah, that's right it is a signal transduction regulator. I remember nJOEBT1-1/5/2003
1311No opinion on Novogen, but Phenoxodiol does not appear to be a proteasome inhibituck-1/4/2003
1310Joe Sorry Joe, I have no opinion on Phenoxodiol or Novogen. I could however recIcebrg-1/4/2003
1309Ice--I believe that Novogen's Phenoxodiol is a proteasome inhibitor. The stoJOEBT1-1/4/2003
1308CaPCURE 2002 At last year's conference Julian Adams gave a presentation &quIcebrg-1/4/2003
1307Millennium man By Naomi Aoki, Globe Staff, 12/12/2001 CAMBRIDGE -- For years,Icebrg-12/31/2002
1306And while on the subject of googling for PS-341. I also the following article wrIcebrg-12/31/2002
1305Sales, you asked >>does anyone know whether mlnm pays the full costs of tIcebrg-12/31/2002
1304does anyone know whether mlnm pays the full costs of these studies or are they bsoftware salesperson-12/31/2002
1303In their recent PR Millennium said about Velcade and clinical trials: <i>Icebrg-12/31/2002
1302Sales, Your question list is very long. I would start with ""3. debMiljenko Zuanic-12/30/2002
1301here are the areas which I would like to see addressed at h&q and the 4 q ccsoftware salesperson-12/30/2002
1300Millennium Initiates Phase II Clinical Trial With VELCADE(TM) (Bortezomib) for IIcebrg-12/30/2002
1299Investors Lose Faith in Millennium Pharmaceuticals Despite Promising Signs CAbob zagorin-12/26/2002
1298From Yahoo a link to a very good presentation on velcade medsessions.com 2002scott mcdowell-12/26/2002
1297XOMA Receives $7.5 Million From Millennium Under Existing Development Arrangemenbob zagorin-12/24/2002
1296New patent related to antibody inhibition of CCR4: patft.uspto.gov Snip from ttuck-12/21/2002
1295CAMBRIDGE, Mass., Dec. 20 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, nigel bates-12/20/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News